Survodutide
Survodutide (BI 456906) is a lipidated glucagon and GLP-1 receptor dual agonist peptide. Approved business buyers can apply for wholesale access.
US Peptide Distributors supplies Survodutide at wholesale to approved business buyers. Every lot is tested by an independent third-party laboratory (we use Freedom Diagnostics and ILS Labs): HPLC for purity and mass spectrometry for identity. Pricing is quoted by supply option: USA stock, USA-synthesized or overseas-sourced, and USA stock offers same-day shipping with no minimum order.
Updated
- Synonyms
- BI 456906, BI-456906
- Formula
- C192H289N47O61
- Molecular weight
- 4232 g/mol
- CAS number
- 2805997-46-8
Approved buyers see pricing
Wholesale pricing is available to approved business buyers after they log in.
Supply and testing
- Every lot third-party testedHPLC for purity, mass spectrometry for identity. Labs: Freedom Diagnostics and ILS Labs.
- Three supply optionsSupply options for wholesale ordersUSA stock (ships from US inventory), USA-synthesized, overseas-sourced.Ask which options apply to this compound.
- Same-day shipping on USA stockExpedited options available. Overseas-sourced orders typically take 7-10 days.
- No minimum on USA stockOne box to thousands of kits, plus gram and kilogram powder.
- COA in your company nameCan be added to an order and is provided with it.
Distributor programShipping times
Request a quote for SurvodutideMolecular identity
Survodutide, developed under the code BI 456906, is a synthetic peptide of roughly 4.2 kDa. The PubChem record shows that it is not a plain linear sequence of natural residues. Position 2 is occupied by the non-proteinogenic amino acid 1-aminocyclobutanecarboxylic acid, one lysine carries a side-chain extension built from a glycine-serine linker and a C18 diacid fatty chain, and the C-terminus is an amide. Those features are characteristic of peptides engineered for stability, and each one is a point a mass-spectrometry identity check should confirm.
Class
The compound is described in the literature as a dual agonist of the glucagon receptor (GCGR) and the GLP-1 receptor (GLP-1R). Their natural ligands belong to the proglucagon-derived peptide family: a 2021 review explains that glucagon, GLP-1, GLP-2 and oxyntomodulin are all processed from a single precursor, and discusses how dual and triple receptor agonists were designed by combining their activities. A 2023 review on oxyntomodulin-based co-agonists covers the structure-activity logic behind designs that engage both receptors.
Mapping its site of action
The most specific mechanistic paper in the list is a 2026 study from the group that developed it. The authors examined where the two receptors are expressed in human and mouse circumventricular organs, the brain regions with a leaky barrier. They report that GCGR is barely detectable in the area postrema and arcuate nucleus. Using a fluorophore-labelled version of survodutide, they saw it reach the circumventricular organs and adjacent hypothalamic and hindbrain nuclei, without evidence of uniformly crossing the blood-brain barrier. c-Fos labelling then showed activation in multiple nuclei associated with the control of food intake, and a long-acting GCGR-only agonist did not reproduce the activation in satiety-mediating regions. The authors read this as supporting a dual mode of action.
Scope of this page
Survodutide has been evaluated in human clinical trials, and this page does not summarise their results. It is limited to molecular identity, receptor class and mechanism research, and it makes no claim about effects in people.
Sourcing notes
A fatty-acid-modified peptide behaves differently on reverse-phase HPLC from an unmodified one, so retention times are not comparable across compounds. Ask for the observed intact mass, and read our guide on purity, net content and counterions to understand how a stated purity relates to the actual peptide content of a vial.
Supply is for approved business buyers, for laboratory research use only.
References
- Zimmermann T, et al. Survodutide acts through circumventricular organs in the brain and activates neuronal regions associated with appetite regulation. Mol Metab. 2026.
- Lafferty RA, et al. Proglucagon-Derived Peptides as Therapeutics. Front Endocrinol (Lausanne). 2021.
- Zhihong Y, et al. Emerging roles of oxyntomodulin-based glucagon-like peptide-1/glucagon co-agonist analogs in diabetes and obesity. Peptides. 2023.
Questions
Where can I buy Survodutide in bulk?
US Peptide Distributors supplies Survodutide to approved business buyers. Apply for a buyer account to see wholesale pricing by supply option (USA stock, USA-synthesized or overseas-sourced). There is no minimum order on USA stock, and larger volumes are quoted on request.
Is Survodutide sold for use in humans?
No. US Peptide Distributors sells Survodutide to approved business buyers for laboratory research use only, not for use in humans.
Is each lot of Survodutide third-party tested?
Yes. Every lot US Peptide Distributors supplies is tested by an independent third-party laboratory (we use Freedom Diagnostics and ILS Labs): HPLC for purity and mass spectrometry for identity. Lot COAs appear on this page as they are uploaded.